VIENNA, Austria—Semperit A.G. Holding expects to report an impairment loss of approximately $50 million for its medical sector, Sempermed, in the third quarter of 2022, the Austrian group has announced.

"Against the backdrop of the market dynamics for examination and protective gloves, the executive board reviewed the estimates and assumptions relevant to the valuation with regard to the medical sector," said a group statement Sept. 13.

"As a result, a probable impairment loss in the order of approximately €50 million (about $50.1 million) as of (Sept. 30), 2022 was identified for the segment assets of Sempermed," it added.

Semperit said it would include the impairment loss in its third quarter results, which will be published Nov. 16.

The medical gloves sector, which Semperit currently intends to divest, reported a 93-percent year-on-year decline in earnings to $15.6 million in the first half of the year, as sales fell 50 percent to $198.6 million.

Semperit linked the decline to a sharp fall in price levels following the end of the boom in demand for medical protective gloves.

Furthermore, significant cost increases weighed on the unit as it returned to normality following two years of strong performance.

Rubber News wants to hear from its readers. If you want to express your opinion on a story or issue, email your letter to Editor Bruce Meyer at [email protected] .

Please enter a valid email address.

Please enter your email address.

Please select at least one newsletter to subscribe.

Staying current is easy with Rubber News delivered straight to your inbox, free of charge.

Subscribe to Rubber News to get the best coverage and leading insights in the industry.

To serve companies in the global rubber product industry by delivering news, industry insights, opinions and technical information.

2291 Riverfront Pkwy, Suite 1000 Cuyahoga Falls, OH 44221